Alzheimer’s drug trials plagued by lack of racial diversity
Author:
- Sara ReardonSRSara Reardon
- 2 August 2023
- journal article
- news
- Published by Springer Nature in Nature
- Vol. 620 (7973) , 256-257
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Association of African Ancestry–Specific APOE Missense Variant R145C With Risk of Alzheimer DiseaseJAMA, 2023
- Lecanemab in Early Alzheimer’s DiseaseNew England Journal of Medicine, 2023
- Diversity in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Lecanemab and Elenbecestat Early Alzheimer’s Disease StudiesAlzheimer's & Dementia, 2022
- Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sampleMolecular Psychiatry, 2022